Treatment of Alcohol Abuse
Initial Assessment and Intervention Strategy
- The American College of Physicians recommends implementing the FRAMES model as the first-line approach for hazardous drinkers and those with mild alcohol use disorder 1, 3
- Brief interventions are effective at reducing morbidity and mortality related to drinking and should be delivered in 5-30 minutes incorporating individualized feedback and advice on reducing or stopping alcohol consumption, as suggested by the World Health Organization 1, 4
Psychosocial Treatment Framework
- The National Institute on Alcohol Abuse and Alcoholism recommends actively encouraging engagement with Alcoholics Anonymous (AA) as it is highly effective in treating alcohol use disorder and should be routinely recommended as part of comprehensive treatment 4, 5
- Cognitive behavioral therapy (CBT) should be implemented to help patients develop coping skills and address the psychological patterns underlying their drinking behavior, according to the American Psychological Association 1, 6
Pharmacotherapy for Maintaining Abstinence
- The European Medicines Agency recommends acamprosate as the only medication with sufficient high-quality evidence demonstrating superiority over placebo for maintaining alcohol abstinence in primary care settings 2
- Naltrexone (50 mg daily) can reduce relapse to heavy drinking and drinking frequency, but requires careful patient selection, as stated by the National Institute on Alcohol Abuse and Alcoholism 4, 6
Management of Alcohol Withdrawal
- The American Academy of Family Physicians recommends benzodiazepines as the front-line medication for managing withdrawal, alleviating discomfort, and preventing seizures and delirium 4
- Patients at risk of severe withdrawal, those with concurrent serious physical or psychiatric disorders, or those lacking adequate support should be managed in an inpatient setting, according to the American Medical Association 4
Critical Pitfalls to Avoid
- The American College of Gastroenterology warns to never use naltrexone in patients with alcoholic liver disease due to hepatotoxicity risk 6
- The American Society of Addiction Medicine advises against relying on AA attendance alone for patients with severe dependence or significant psychiatric comorbidities who require more intensive professional treatment 5
Monitoring and Long-Term Management
- The National Committee for Quality Assurance recommends regular follow-up appointments every 1-3 months to assess progress and adjust treatment 3
- The Substance Abuse and Mental Health Services Administration emphasizes that continued engagement with treatment is essential even after achieving initial abstinence, as relapse rates can reach 50% at one year 3